Two novel histone deacetylase inhibitors against human pancreatic cancer
Thursday, October 16, 2008 - 08:00
in Health & Medicine
Pancreatic cancer is the fifth to sixth leading cause of cancer death in Europe and the fourth leading cause of cancer death in the USA. The lethality of this malignancy is demonstrated by the fact that the annual incidence is approximately equal to the annual deaths...
Read the whole article on Science Centric
More from Science Centric
Related
- Annual report to the nation finds declines in cancer incidence and death ratesTue, 25 Nov 2008, 16:23:38 EST
- New drug achieves pancreatic cancer tumor remission and prevents recurrenceSun, 19 Apr 2009, 15:29:49 EDT
- Popular diabetes treatment could trigger pancreatitis, pancreatic cancerThu, 30 Apr 2009, 15:45:22 EDT
- A promising approach in the prevention and treatment of pancreatic cancerThu, 25 Sep 2008, 9:43:12 EDT
- An herbal extract inhibits the development of pancreatic cancerSun, 19 Apr 2009, 10:29:07 EDT